Therapeutic regimen of L-arginine for MELAS: 9-year, prospective, multicenter, clinical research.
Yasutoshi KogaNataliya PovalkoEisuke InoueHidefumi NakamuraAkiko IshiiYasuhiro SuzukiMakoto YonedaFumio KandaMasaya KubotaHisashi OkadaKatsunori FujiiPublished in: Journal of neurology (2018)
The systematic administration of oral and intravenous L-arginine may be therapeutically beneficial and clinically useful for patients with MELAS.